NCT03072277 - Maternal DHA Supplementation and Offspring Neurodevelopment in India (DHANI-2) | Biotech Hunter

Enrollment

957

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

April 30, 2019

Study Completion Date

December 31, 2020

Conditions

Pregnancy

Interventions

DIETARY_SUPPLEMENT

Docosa Hexaenoic Acid (DHA)

400 mg/day of Docosa-hexaenoic Acid (algal DHA) will given to the pregnant women (in the active group) from ≤20 weeks of gestation through 6 months postpartum.

DIETARY_SUPPLEMENT

Placebo

400 mg/day of placebo (corn/soy oil) will be given to the pregnant women from ≤20 weeks of gestation through 6 months postpartum.

Trial Locations (1)

590010

KLEUs Jawaharlal Nehru Medical College -- Prabhakar Kore Charitable Hospital, Belagavi